4:3 intermittent fasting effective for weight loss among adults with obesity
1. In this randomized controlled trial, 4:3 intermittent fasting was associated with significantly greater weight loss compared with daily caloric ...
Tag: weight loss
Glucagon-like peptide-1 receptor agonists and co-agonists safe and effective for weight loss
1. In this systematic review, glucagon-like peptide-1 receptor agonists and co-agonists were effective in inducing weight loss in overweight adults ...
The Scan by 2 Minute Medicine®: Versatile Ozempic, Healthcare Reform, Unlocking the Brain, and Chickens and the Next Pandemic:
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. We ...
#Visual Abstract: Semaglutide Imrpoves Weight Loss Gains and Pain Related to Knee Osteoarthritis in Patients with Obesity
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Weight loss interventions may improve metabolic and reproductive outcomes in polycystic ovarian syndrome
1. In this systematic review and meta-analysis, weight loss interventions for overweight people with polycystic ovary syndrome were associated with ...
Altimmune: GLP-1/Glucagon Receptor Agonist Pemvidutide Preserves Lean Mass During Weight Loss
Patients on pemvidutide experienced only 21.9% of weight loss attributable to lean mass. Pemvidutide preserves muscle tissue and prioritizes fat ...
Telephone coaching program may help patients achieve weight loss
1. The addition of 3 or 12 weeks of telephone coaching for individuals with suboptimal response in an online weight ...
#VisualAbstract: Wireless Feedback System was Not Non-inferior to the Same System Plus Coaching in Achieving Weight Loss Goals
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be ...
Roche: CT-388 Dual GLP1-GIP Receptor Agonist Clinically Improves Weight Loss
Patients who received CT-388 had an average placebo-adjusted weight loss of 18.8%. CT-388 is well tolerated with only mild to ...
Eli Lilly: Tirzepatide Shows Promise In Treating Obstructive Sleep Apnea In Two Phase 3 Clinical Trials
Tirzepatide led to a 63% mean reduction in restricted/obstructed breathing events per hour in patients with moderate to severe obstructive ...